QTRX logo

QTRX
Quanterix Corp

1,103
Mkt Cap
$118.71M
Volume
973,993.00
52W High
$8.77
52W Low
$2.49
PE Ratio
-1.06
QTRX Fundamentals
Price
$2.51
Prev Close
$2.52
Open
$2.50
50D MA
$3.60
Beta
1.72
Avg. Volume
988,321.22
EPS (Annual)
-$2.51
P/B
0.42
Rev/Employee
$308,660.00
$190.19
Loading...
Loading...
News
all
press releases
Quanterix Announces Planned Transition of Chief Financial Officer
Quanterix Corporation (Nasdaq: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced that Vandana Sriram, its Chief Financial Officer (CFO) will depart the Company. A search for her successor is ongoing, and Ms. Sriram will...
Business Wire·7d ago
News Placeholder
More News
News Placeholder
Quanterix Corporation (QTRX) Reports Q1 Loss, Lags Revenue Estimates
Quanterix (QTRX) delivered earnings and revenue surprises of -25.81% and -0.67%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks·13d ago
News Placeholder
Quanterix Releases Financial Results for the First Quarter of 2026
Quanterix Corporation (NASDAQ: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced financial results for the first quarter...
Business Wire·13d ago
News Placeholder
Lucent Diagnostics Announces Collaboration with Tempus to Integrate Blood-Based Alzheimers Biomarker Testing into Clinical Workflows
Lucent Diagnostics, a brand of Quanterix Corporation (NASDAQ: QTRX), today announced a collaboration with Tempus AI Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance...
Business Wire·13d ago
News Placeholder
Quanterix (QTRX) Expected to Announce Quarterly Earnings on Wednesday
Quanterix (NASDAQ:QTRX) will be releasing its Q1 2026 earnings after the market closes on Wednesday, May 6. (View Earnings Report at...
MarketBeat·20d ago
News Placeholder
Quanterix To Report First Quarter 2026 Financial Results on May 6, 2026
Quanterix Corporation (Nasdaq: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced that it will host a conference call on...
Business Wire·25d ago
News Placeholder
Wall Street Zen Downgrades Quanterix (NASDAQ:QTRX) to Sell
Wall Street Zen cut shares of Quanterix from a "hold" rating to a "sell" rating in a report on Saturday...
MarketBeat·1mo ago
News Placeholder
AidaBREAST Multi-Omic Assay Demonstrates Spatial Proteomics for Clinical Oncology
PreludeDx and Quanterix Corporation (Nasdaq: QTRX) today highlighted that AidaBREAST, the first multi-omic assay to predict both locoregional recurrence risk and radiation therapy benefit in early-stage invasive breast cancer, was developed on Akoya PhenoImager HT platform using Opal chemistry...
Business Wire·1mo ago
News Placeholder
Quanterix Debuts Content Innovation Engine at AACR 2026
Quanterix Corporation (Nasdaq: QTRX) today announced plans to debut its Content Innovation Engine at the American Association for Cancer Research (AACR) Annual Meeting 2026. Built on the integration...
Business Wire·1mo ago
News Placeholder
Aberdeen Group plc Trims Stock Holdings in Quanterix Corporation $QTRX
Aberdeen Group plc reduced its position in shares of Quanterix Corporation (NASDAQ:QTRX - Free Report) by 81.6% during the 4th quarter, according to its most recent 13F filing with the Securities...
MarketBeat·1mo ago
<
1
2
...
>

Latest QTRX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.